Who Paid My Doc
Kybella
Biological
NDC 61168-101-04
General payments
$1,114,850
Research payments
$659,044
Through program year 2025, $1,114,850 in general payments and $659,044 in research payments were reported against Kybella.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $46,833 | 52 |
| 2024 | General | $107,160 | 210 |
| 2024 | Research | $38,400 | 2 |
| 2023 | General | $381,842 | 531 |
| 2022 | General | $108,543 | 189 |
| 2022 | Research | $40,468 | 1 |
| 2021 | General | $180,279 | 165 |
| 2021 | Research | $145,848 | 5 |
| 2020 | General | $212,394 | 112 |
| 2020 | Research | $3,972 | 1 |
| 2019 | General | $77,799 | 184 |
| 2019 | Research | $430,356 | 12 |
Breakdown
The top 5 of 29 recipients; each share is of general payments naming this product in 2025.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,443 general · 21 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.